Jennifer Jones
- Virology top 1%
- HIV Research and Treatment 10
- Immunology top 10%
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 3
- Microbiology top 5%
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 4
- HIV/AIDS Research and Interventions 2
-
- vaccines and immunoinformatics approaches 1
-
- Diabetes and associated disorders 1
- Co-authors
- Melissa PopeRonald S. VeazeyPer Johan KlasseDennis R. BurtonQinxue HuJohn P. MoorePreston A. MarxRobin J. Shattock
- Cited by
- VirologyImmunologyMicrobiology
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Jennifer Jones
16 papers receiving 824 citations
Peers
Comparison fields: 5 of 71
- Virology 511
- Immunology 388
- Microbiology 87
- Infectious Diseases 231
- Biotechnology 39
Countries citing papers authored by Jennifer Jones
This map shows the geographic impact of Jennifer Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Jones more than expected).
Fields of papers citing papers by Jennifer Jones
This network shows the impact of papers produced by Jennifer Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Jones. The network helps show where Jennifer Jones may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jennifer Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2021 | 9 | |
| 3 | 2018 | 47 | |
| 4 | 2017 | 31 | |
| 5 | 2012 | 8 | |
| 6 | 2012 | 81 | |
| 7 | 2007 | 16 | |
| 8 | 2006 | 5 | |
| 9 | 2006 | 45 | |
| 10 | 2004 | 13 | |
| 11 | 2004 | 57 | |
| 12 | 2004 | 25 | |
| 13 | 2003 | 375 | |
| 14 | 2001 | 3 | |
| 15 | A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. | 1987 | 107 |
| 16 | 1977 | 10 |
About Jennifer Jones
Jennifer Jones is a scholar working on Virology, Immunology and Infectious Diseases, having authored 16 papers that have together received 837 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers), HIV/AIDS drug development and treatment (4 papers), Immunotherapy and Immune Responses (3 papers), HIV/AIDS Research and Interventions (2 papers), vaccines and immunoinformatics approaches (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Virology (511 citations), Immunology (388 citations) and Microbiology (87 citations). Jennifer Jones has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Melissa Pope, Ronald S. Veazey, Per Johan Klasse, Dennis R. Burton, Qinxue Hu, John P. Moore, Preston A. Marx, Robin J. Shattock, Tom Ketas and Anastasia Gabriel. Their work appears in journals such as Journal of Virology, BioTechniques, SLAS DISCOVERY, The Journal of Immunology and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.